comparemela.com

Latest Breaking News On - Essa pharma inc - Page 10 : comparemela.com

ESSA Pharma to Present at Oppenheimer Annual Healthcare Conference

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesSouth san franciscoBritish columbiaDavids woodPeter virsikPharma incAnnual healthcare conferenceChief executive officerOperating officerFinancial officerEssa pharma inc

ESSA Pharma to Present Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders at the 2022 American Association for Cancer Research (AACR) Annual Meeting

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaNan hyung hongOrleans convention centerAmerican association for cancer researchPharma incCancer researchN terminal domainProtein degradersNew orleans convention centerExhibit hallsd hPoster sectionEssa pharma inc

ESSA Pharma Announces First Patient Dosed in a Phase 1/2 Clinical Trial of EPI-7386 in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

/PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the.

United statesBritish columbiaAstellas pharma incPfizer incHealth canadaPharma incCompany sponsored phaseAstellas pharmaChief executive officerNew drugFast trackLooking statement disclaimer thisPrivate securities litigation reform actEssa pharma inc

ESSA Pharma Presents at 28th Annual Prostate Cancer Foundation Scientific Retreat

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.

United statesBritish columbiaNan hyung hongVirtual international conference on molecularHealth canadaPharma incProstate cancer foundationCancer foundationScientific retreatInternational conferenceMolecular targetsNan hyungFast trackPrivate securities litigation reform actEssa pharma inc

Hedge Funds Are Done Buying ESSA Pharma Inc (EPIX)

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.

Phillip grossNeil shahrestani ikarianDevesh gandhiEssa pharma incCitadel investment groupArko corpBiotechnology value fundMetromile incRepare therapeutics incAmerisafe incGreen brick partners incPharma incAaron company incInsider monkeyGross adage capital phillipGood stock to buy

vimarsana © 2020. All Rights Reserved.